MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 9 (3) , 325-331
- https://doi.org/10.1016/j.cbpa.2005.04.004
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- B-RAF is a therapeutic target in melanomaOncogene, 2004
- Enzymes play molecular tagNature, 2004
- Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potentialBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2004
- Specificity in Signal TransductionCell, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding SitesCurrent Biology, 2003
- Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic interventionLeukemia, 2003
- SUMO-1 Modification of the C-terminal KVEKVD of Axin Is Required for JNK Activation but Has No Effect on Wnt SignalingJournal of Biological Chemistry, 2002
- TAK1 is a ubiquitin-dependent kinase of MKK and IKKNature, 2001
- Disruption of Signaling by Yersinia Effector YopJ, a Ubiquitin-Like Protein ProteaseScience, 2000